Bibliografía del artículo
1. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, y col. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 68(3):241-51, 2011.
2. Secunda SK, Swann A, Katz MM, Koslow SH, Croughan J, Chang S. Diagnosis and treatment of mixed mania. Am J Psychiatry 144(1):96-8, 1987.
3. Altshuler LL, Kupka RW, Hellemann G, Frye MA, Sugar CA, McElroy SL, y col. Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network. Am J Psychiatry 167(6):708-15, 2010.
4. Kawa I, Carter JD, Joyce PR, Doughty CJ, Frampton CM, Wells JE, y col. Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation. Bipolar Disord 7(2):119-25, 2005.
5. Arnold LM. Gender differences in bipolar disorder. Psychiatr Clin North Am 26(3):595-620, 2003.
6. Baskaran A, Cha DS, Powell AM, Jalil D, McIntyre RS. Sex differences in rates of obesity in bipolar disorder: postulated mechanisms. Bipolar Disord 16(1):83-92, 2014.
7. Bauer M, Glenn T, Pilhatsch M, Pfennig A, Whybrow PC. Gender differences in thyroid system function: relevance to bipolar disorder and its treatment. Bipolar Disord 16(1):58-71, 2014.
8. Teatero ML, Mazmanian D, Sharma V. Effects of the menstrual cycle on bipolar disorder. Bipolar Disord 16(1):22-36, 2014.
9. Rasgon N, Bauer M, Glenn T, Elman S, Whybrow PC. Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disord 5(1):48-52, 2003.
10. Dias RS, Lafer B, Russo C, Del Debbio A, Nierenberg AA, Sachs GS, y col. Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. Am J Psychiatry 168(4):386-94, 2011.
11. Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, y col. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 164(12):1817-24; quiz 1923, 2007.
12. Freeman MP, Smith KW, Freeman SA, McElroy SL, Kmetz GE, Wright R, y col. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 63(4):284-7, 2002.
13. Viguera AC, Tondo L, Koukopoulos AE, Reginaldi D, Lepri B, Baldessarini RJ. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry 168(11):1179-85, 2011.
14. Munk-Olsen T, Laursen TM, Meltzer-Brody S, Mortensen PB, Jones I. Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders. Arch Gen Psychiatry 69(4):428-34, 2012.
15. Munk-Olsen T, Jones I, Laursen TM. Birth order and postpartum psychiatric disorders. Bipolar Disord 16(3):300-7, 2014.
16. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 111(4):1001-20, 2008.
17. Hale T. Medications in mother's milk. Pharmasoft Publishing, 2004.
18. Chandane PG, Shah I. Fetal valproate syndrome. Indian J Hum Genet 20(2):187-8, 2014.
19. Galbally M, Roberts M, Buist A. Mood stabilizers in pregnancy: a systematic review. Aust N Z J Psychiatry 44(11):967-77, 2010.
20. Gentile S. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions. CNS Spectr 19(4):305-15, 2014.
21. Jacobsen PE, Henriksen TB, Haubek D, Østergaard JR. Prenatal exposure to antiepileptic drugs and dental agenesis. PLoS One 9(1):e84420, 2014.
22. Akar M, Dilli D, Yilmaz Y, Erdeve O, Oguz S, Uras N, y col. A case of fetal carbamazepine syndrome with right hemihypoplasia of the entire body. Genet Couns 23(1):19-24, 2012.
23. Dursun A, Karada N, Karagöl B, Kundak AA, Zenciroclu A, Okumul N, y col. Carbamazepine use in pregnancy and coincidental thalidomide-like phocomelia in a newborn. J Obstet Gynaecol 32(5):488-9, 2012.
24. Matlow J, Koren G. Is carbamazepine safe to take during pregnancy? Can Fam Physician 58(2):163-4, 2012.
25. Bergink V, Kushner SA. Lithium during pregnancy. Am J Psychiatry 171(7):712-5, 2014.
26. Diav-Citrin O, Shechtman S, Tahover E, Finkel-Pekarsky V, Arnon J, Kennedy D, y col. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry 171(7):785-94, 2014.
27. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 63(4):385-90, 2006.
28. Blehar MC, DePaulo JR, Gershon ES, Reich T, Simpson SG, Nurnberger JI. Women with bipolar disorder: findings from the NIMH Genetics Initiative sample. Psychopharmacol Bull 34(3):239-43, 1998.
29. Marsh WK, Ketter TA Rasgon NL. Increased depressive symptoms in menopausal age women with bipolar disorder: age and gender comparison. J Psychiatr Res 43(8):798-802, 2009.
30. Marsh WK, Ketter TA, Crawford SL, Johnson J V, Kroll-Desrosiers AR, Rothschild AJ. Progression of female reproductive stages associated with bipolar illness exacerbation. Bipolar Disord 14(5):515-26, 2012.
31. Gaspar-Barba E, De la Peña F. Neuroendocrine disturbances in pediatric population with major depressive disorder. In: De Gortari P, editor. Psychoneuroendocrinology Kerala, India, pp. 1-21, 2011.
32. Rasgon NL, Altshuler LL, Fairbanks L, Elman S, Bitran J, Labarca R, y col. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord 7(3):246-59, 2005.
33. Reynolds-May MF, Kenna HA, Marsh W, Stemmle PG, Wang P, Ketter TA, y col. Evaluation of reproductive function in women treated for bipolar disorder compared to healthy controls. Bipolar Disord 16(1):37-47, 2014.
34. Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 84(2):573-7, 1999.
35. Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V, y col. Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study. J Clin Endocrinol Metab 81(10):3578-83, 1996.
36. Seidman SN, Spatz E, Rizzo C, Roose SP. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry 62(6):406-12, 2001.
37. Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 15(4):289-305, 2009.
38. Sher L, Grunebaum MF, Sullivan GM, Burke AK, Cooper TB, Mann JJ, y col. Testosterone levels in suicide attempters with bipolar disorder. J Psychiatr Res 46(10):1267-71, 2012.
39. Yates WR, Perry PJ, MacIndoe J, Holman T, Ellingrod V. Psychosexual effects of three doses of testosterone cycling in normal men. Biol Psychiatry 45(3):254-60, 1999.
40. Pope HG, Kouri EM, Hudson JI. Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry 57(2):133-40; discussion 155-6, 2000.
41. Akdeniz F, Taneli F, Noyan A, Yüncü Z, Vahip S. Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women? Prog Neuropsychopharmacol Biol Psychiatry 27(1):115-21, 2003.
42. McIntyre RS, Mancini DA, McCann S, Srinivasan J, Kennedy SH. Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord 5(1):28-35, 2003.
43. Nelson-DeGrave VL, Wickenheisser JK, Cockrell JE, Wood JR, Legro RS, Strauss JF, y col. Valproate potentiates androgen biosynthesis in human ovarian theca cells. Endocrinology 145(2):799-808, 2004.
44. Markowitz JS, Carson WH, Jackson CW. Possible dihydroepiandrosterone-induced mania. Biol Psychiatry 45(2):241-2, 1999.
45. Vacheron-Trystram MN, Cheref S, Gauillard J, Plas J. A case report of mania precipitated by use of DHEA. Encephale 28(6 Pt 1):563-6, 2002.
46. Rabkin JG, McElhiney MC, Rabkin R, McGrath PJ, Ferrando SJ. Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS. Am J Psychiatry 163(1):59-66, 2006.
47. Gallagher P, Watson S, Smith MS, Young AH, Ferrier IN. Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder. Schizophr Res 90(1-3):258-65, 2007.
48. Dean CE. Prasterone (DHEA) and mania. Ann Pharmacother 34(12):1419-22, 2000.
49. Meinhard N, Kessing LV, Vinberg M. The role of estrogen in bipolar disorder, a review. Nord J Psychiatry 68(2):81-7, 2014.
50. Matsuoka K, Yasuno F, Inoue M, Yamamoto A, Kudo T, Kitamura S, y col. Microstructural changes of the nucleus accumbens due to increase of estradiol level during menstrual cycle contribute to recurrent manic episodes--a single case study. Psychiatry Res 221(2):149-54, 2014.
51. Kelley SP, Alan JK, O'Buckley TK, Mennerick S, Krishnan K, Covey DF, y col. Antagonism of neurosteroid modulation of native gamma-aminobutyric acid receptors by (3alpha,5alpha)-17-phenylandrost-16-en-3-ol. Eur J Pharmacol 572(2-3):94-101, 2007.
52. Hardoy MC, Sardu C, Dell'osso L, Carta MG. The link between neurosteroids and syndromic/syndromal components of the mood spectrum disorders in women during the premenstrual phase. Clin Pract Epidemiol Ment Health 4:3, 2008.
53. Carta MG, Bhat KM, Preti A. GABAergic neuroactive steroids: a new frontier in bipolar disorders? Behav Brain Funct 8:61, 2012.
54. Bowden CL. Anticonvulsants in bipolar disorders: current research and practice and future directions. Bipolar Disord 11(Suppl 2):20-33, 2009.
55. Grunze HCR. Anticonvulsants in bipolar disorder. J Ment Health 19(2):127-41, 2010.
56. Marx CE, Yuan P, Kilts JD, Madison RD, Shampine LJ, Manji HK. Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice. Int J Neuropsychopharmacol 11(4):547-52, 2008.